JPRN-jRCT2080220876未知2 期
Phase 2 Dose-finding, Double-blind Controlled Study of SFPP in Knee Osteoarthritis 2nd
Taisho Pharmaceutical co., LTD0 个研究点目标入组 500 人开始时间: 2009年9月26日最近更新:
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Outpatient able to walk
- •- Patients who agreed to X-ray diagnosis criteria: Kellegren-Lawrence grade 2-3.
排除标准
- •- Patients who underwent surgery (including arthroscopy) in their knees.
- •- Patients with comorbid serious hepatic, renal, cardiac, or hematologic disease or malignancy
研究者
相似试验
进行中（未招募）
1 期
Study of APD403 in the prevention of sickness caused by some chemotherapy drugsEUCTR2013-001635-51-DKAcacia Pharma Ltd315
进行中（未招募）
1 期
Study of APD403 in the prevention of sickness caused by some chemotherapy drugsEUCTR2013-001635-51-GBAcacia Pharma Ltd328
进行中（未招募）
1 期
Study of APD403 in the prevention of sickness caused by some chemotherapy drugsEUCTR2013-001635-51-DEAcacia Pharma Ltd315
进行中（未招募）
1 期
Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative ColitisModerate to Severe Active Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2021-002537-41-ITAMGEN INC.320
进行中（未招募）
1 期
A randomized phase 2 study to determine the dose, and assessthe efficacy, safety, and tolerability of Gemcabene in Patients withHypercholesterolemia.HypercholesterolaemiaMedDRA version: 19.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-005756-10-DKGemphire Therapeutics Inc.212